As Monkeypox increasingly threatens global health, India has taken a significant step forward with the Central Drugs Standard Control Organisation’s (CDSCO) approving a new indigenously developed RT-PCR testing kit that can deliver results within 40 minutes.
The IMDX Monkeypox Detection RT-PCR Assay, created by Siemens Healthineers, is designed to detect both clade I and clade II variants of the virus.
This advancement marks a crucial milestone for India’s “Make in India” initiative and is a pivotal addition to the country’s arsenal in combating the Monkeypox public health emergency.
“IMDX Monkeypox Detection RT-PCR Assay will be manufactured at our molecular diagnostics manufacturing unit in Vadodara, which has a manufacturing capacity of 1 million reactions per year. The factory is all set to make the kits available,” said Siemens Healthcare Private Ltd.
